Nader G. Abraham, Ph.D., DR.H.C., is currently the Vice Dean for Research at Marshall University Joan C. Edwards School of Medicine and the former chair of the Department of Physiology and Pharmacology at the University of Toledo. He is also a member of the faculty of Rockefeller University, NY and New York Medical College, NY. He is supported by 4 NIH grants, two of which are funded until 2015 and 2016.

He is a former chairman of the International Society of Experimental Hematology, and has served as chair of The International Symposium on Treatments of Stem Cells, Leukemia and Cancer. He has lectured extensively throughout the world, and has authored or co-authored more than 300 peer-reviewed articles and more than 50 book chapters and reviews. He is editor of seven books and also serves on several NIH Study sections.

The major focus of his laboratory is the investigation of the participation of the antioxidants, heme oxygenase, in the regulation of stem cells and vascular systems in human and animal models of hypertension, diabetes and metabolic syndrome. His laboratory has demonstrated that Heme oxygenase-1 is key in the protection of stem cell function and provides a defense system to the vascular endothelium. Increased heme oxygenase-1 expression and heme oxygenase activity improve adiposity and vascular function and ameliorate oxidative stress in the body. He and his colleagues are also investigating the effect of anti-diabetic drugs and insulin sensitizers such as pioglitzone and rosiglitazone on the development of cardiac vascular diseases (CVD).